Abstract
Purpose
Homeostasis Model Assessment-estimated Insulin Resistance (HOMA-IR) is an important indicator of insulin resistance. In this population-based investigation, we sought to report the mean value of HOMA-IR in different subgroups of a large population-based database of Iranian healthy subjects.
Methods
This study recruited adult healthy individuals between the ages of 18 to 70 years old to Massoud Medical Laboratory, Tehran, Iran. Fasting insulin was measured by using the Electro Chemiluminescence method using Roche Cobas 6000 e601/602 instrument.
Results
The mean ± SD value of the HOMA-IR index in the studied population was 2.11 ± 0.99 (2.5-97.5% percentiles: 0.66–4.50). In addition, the mean ± SD of HOMA-IR index in male and female groups were 2.35 1.0 (2.5-97.5 percentile: 0.57–4.37) and 2.05 ± 1.0 (2.5-97.5 percentiles: 0.53–4.35), respectively. Interestingly, it was observed a significant increment for the HOMA-IR index in the male group compared with the female group in all age subgroups (P < 0.01).
Conclusions
Our findings showed the mean value of 2.11 ± 0.99 HOMA-IR in the Iranian healthy population. Considering the large sample size in our study, more clinical investigations in terms of ethnicity should be done to provide a precise standardized HOMA-IR index in the Iranian population.
Similar content being viewed by others
Data Availability
The data and materials that support the findings of this study are available from the corresponding author upon reasonable request.
References
Spoto B, Pisano A, Zoccali C. Insulin resistance in chronic kidney disease: a systematic review. Am J Physiol Ren Physiol. 2016;311(6):F1087-f108.
Yaribeygi H, Farrokhi FR, Butler AE, Sahebkar A. Insulin resistance: Review of the underlying molecular mechanisms. J Cell Physiol. 2019;234(6):8152–61.
Sarafidis P, Lasaridis A, Nilsson P, Pikilidou M, Stafylas P, Kanaki A, et al. Validity and reproducibility of HOMA-IR, 1&HOMA-IR, QUICKI and McAuley’s indices in patients with hypertension and type-2 diabetes. Journal of human hypertension. 2007;21:709–16.
de Abreu VG, Martins CJdM, de Oliveira PAC, Francischetti EA. High-molecular weight adiponectin/HOMA-IR ratio as a biomarker of metabolic syndrome in urban multiethnic Brazilian subjects. PLoS ONE. 2017;12(7):e0180947-e.
Isokuortti E, Zhou Y, Peltonen M, Bugianesi E, Clement K, Bonnefont-Rousselot D, et al. Use of HOMA-IR to diagnose non-alcoholic fatty liver disease: a population-based and inter-laboratory study. Diabetologia. 2017;60(10):1873–82.
Nakamura K, Sakurai M, Miura K, Morikawa Y, Nagasawa SY, Ishizaki M, et al. HOMA-IR and the risk of hyperuricemia: a prospective study in non-diabetic Japanese men. Diabetes Res Clin Pract. 2014;106(1):154–60.
Salgado AL, Carvalho L, Oliveira AC, Santos VN, Vieira JG, Parise ER. Insulin resistance index (HOMA-IR) in the differentiation of patients with non-alcoholic fatty liver disease and healthy individuals. Arq Gastroenterol. 2010;47(2):165–9.
Kim JY, Bacha F, Tfayli H, Michaliszyn SF, Yousuf S, Arslanian S. Adipose Tissue Insulin Resistance in Youth on the Spectrum From Normal Weight to Obese and From Normal Glucose Tolerance to Impaired Glucose Tolerance to Type-2 Diabetes. Diabetes Care. 2019;42(2):265–72.
da Silva CdC, Zambon MP, Vasques ACJ, Camilo DF, De Bernardi Rodrigues AM, Antonio MÂRdGM, et al. Homeostatic model assessment of adiponectin (HOMA-Adiponectin) as a surrogate measure of insulin resistance in adolescents: Comparison with the hyperglycaemic clamp and homeostatic model assessment of insulin resistance. PLoS ONE. 2019;14(3):e0214081-e.
Sarafidis PA, Lasaridis AN, Nilsson PM, Pikilidou MI, Stafilas PC, Kanaki A, et al. Validity and reproducibility of HOMA-IR, 1/HOMA-IR, QUICKI and McAuley’s indices in patients with hypertension and type-2 diabetes. J Hum Hypertens. 2007;21(9):709–16.
Burrows R, Correa-Burrows P, Reyes M, Blanco E, Albala C, Gahagan S. Healthy Chilean Adolescents with HOMA-IR ≥ 2.6 Have Increased Cardiometabolic Risk: Association with Genetic, Biological, and Environmental Factors. J Diabetes Res. 2015;2015:783296-.
Yamada C, Mitsuhashi T, Hiratsuka N, Inabe F, Araida N, Takahashi E. Optimal reference interval for homeostasis model assessment of insulin resistance in a Japanese population. J Diabetes Investig. 2011;2(5):373–6.
Tang Q, Li X, Song P, Xu L. Optimal cut-off values for the homeostasis model assessment of insulin resistance (HOMA-IR) and pre-diabetes screening: Developments in research and prospects for the future. Drug discoveries & therapeutics. 2015;9(6):380–5.
Lee CH, Shih AZ, Woo YC, Fong CH, Leung OY, Janus E, et al. Optimal Cut-Offs of Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) to Identify Dysglycemia and Type-2 Diabetes Mellitus: A 15-Year Prospective Study in Chinese. PLoS ONE. 2016;11(9):e0163424.
The International Expert C. International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes. Diabetes Care. 2009;32(7):1327.
Horáková D, Štěpánek L, Janout V, Janoutová J, Pastucha D, Kollárová H, et al. Optimal Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) Cut-Offs: A Cross-Sectional Study in the Czech Population. Medicina (Kaunas, Lithuania). 2019;55(5).
Esteghamati A, Ashraf H, Khalilzadeh O, Zandieh A, Nakhjavani M, Rashidi A, et al. Optimal cut-off of homeostasis model assessment of insulin resistance (HOMA-IR) for the diagnosis of metabolic syndrome: third national surveillance of risk factors of non-communicable diseases in Iran (SuRFNCD-2007). Nutr Metab (Lond). 2010;7:26-.
Nakai Y, Nakaishi S, Kishimoto H, Seino Y, Nagasaka S, Sakai M, et al. The threshold value for insulin resistance on homeostasis model assessment of insulin sensitivity. Diabet medicine: J Br Diabet Association. 2002;19(4):346–7.
Moon S, Park JH, Jang EJ, Park YK, Yu JM, Park JS, et al. The Cut-off Values of Surrogate Measures for Insulin Sensitivity in a Healthy Population in Korea according to the Korean National Health and Nutrition Examination Survey (KNHANES) 2007–2010. J Korean Med Sci. 2018;33(29):e197.
Ghasemi A, Tohidi M, Derakhshan A, Hasheminia M, Azizi F, Hadaegh F. Cut-off points of homeostasis model assessment of insulin resistance, beta-cell function, and fasting serum insulin to identify future type-2 diabetes: Tehran Lipid and Glucose Study. Acta Diabetol. 2015;52(5):905–15.
Gayoso-Diz P, Otero-González A, Rodriguez-Alvarez MX, Gude F, García F, De Francisco A, et al. Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: effect of gender and age: EPIRCE cross-sectional study. BMC Endocr Disord. 2013;13:47-.
Vilela BS, Vasques ACJ, Cassani RSL, Forti ACE, Pareja JC, Tambascia MA, et al. The HOMA-Adiponectin (HOMA-AD) Closely Mirrors the HOMA-IR Index in the Screening of Insulin Resistance in the Brazilian Metabolic Syndrome Study (BRAMS). PLoS ONE. 2016;11(8):e0158751-e.
Singh Y, Garg MK, Tandon N, Marwaha RK. A study of insulin resistance by HOMA-IR and its cut-off value to identify metabolic syndrome in urban Indian adolescents. J Clin Res Pediatr Endocrinol. 2013;5(4):245–51.
Acknowledgements
The authors wish to thank the laboratory staff of Massoud Laboratory and all participants for their helpful enrollment.
Funding
Research work concerning the outputs presented in the manuscript and the Massoud Laboratory supported the manuscript creation, Confirmed proposal number: ML-99-1969-99109.
Author information
Authors and Affiliations
Contributions
Planning of the study was performed with M.KH, M.M. and M.A. Conducting of the study was performed with M.KH, M.M. and M.A. Collecting of the data was carried out by M.KH and M.M, S.M and A.O Interpretation of data was carried out by M.KH and M.M, S.M and A.O. Drafting the manuscript was performed with M.KH, M.M. and M.A. All authors have approved the final draft and agreed to submit the manuscript to this journal.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
All participants signed an informed consent letter. We obtained ethical approval from the Massoud Laboratory (ML-99-1969).
Consent for publication
All authors support submission to this journal.
Competing interests
The authors declare that they have no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Masoodian, S.M., Omidifar, A., Moradkhani, S. et al. HOMA-IR mean values in healthy individuals: a population-based study in iranian subjects. J Diabetes Metab Disord 22, 219–224 (2023). https://doi.org/10.1007/s40200-022-01099-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40200-022-01099-9